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Abstract
 .The control of medial and neointimal growth, in which vascular smooth muscle VSM plays a central role, is most
important to the development of hypertension and atherosclerosis, respectively. Growth of vascular smooth muscle cells is
 .regulated by a number of factors, including the vasodilator nitric oxide NO . In addition, NO modulates intracellular thiol
redox states and the thiol redox state of the cell influences NO production. We, therefore, examined the nature of the effect
of NO on growth of VSM cells and its modulation by cellular glutathione content. Here, we report that NO, either generated
by NO donors or synthesized by iNOS in VSM cells, inhibited DNA synthesis and induced apoptosis in this cell type.
NO-induced apoptosis was associated with a significant decrease in the intracellular concentration of reduced glutathione
and with an increase in the level of the tumor suppressor gene p53 mRNA. Moreover, addition of glutathione
monoethylester to the culture restored the level of reduced glutathione in VSM cells, and prevented the NO-induced
increase in p53 expression and programmed cell death. Our findings suggest a role for reduced glutathione in protecting
VSM cells exposed to NO from apoptosis. q 1997 Elsevier Science B.V.
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1. Introduction
 .Growth control of vascular smooth muscle VSM
within the arterial wall is critical for the development
of pathological processes, including hypertension and
w xatherosclerosis 1,2 . Growth of VSM cells is regu-
lated by a number of factors, including transforming
 .growth factor-b TGF-b , cGMP, heparin and agents
w xthat alter the levels of intracellular cGMP 3,4 . In-
creased levels of cGMP in VSM cells and cell growth
 . w xarrest can be evoked by nitric oxide NO 5 . NO
production, in turn, can modulate cell thiol redox
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state and changes in thiol redox state can affect NO
w xproduction 6–9 . Growth of cells depends on com-
pletion of a full mitotic cell cycle and on rates of cell
death. Cell death in aorta in vitro and in vivo has
been demonstrated by DNA accumulation rates that
w xwere inconsistent with cell mitosis rates 10 . These
observations led us to re-examine the nature of the
effects of NO on VSM cell proliferation, focusing on
 .programmed cell death apoptosis and on its regula-
tion by the cell redox state.
Apoptosis differs from necrosis which occurs when
cells are traumatically injured or are subject to in-
flammatory processes. Apoptosis displays unique
morphological changes, including DNA fragmenta-
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tion, condensation of cytoplasm, nuclear fragmenta-
w xtion, and budding of cell fragments 11,12 . Apopto-
sis is induced in different cell lineages by members
 .of the tumor necrosis factor TNF family, TGF-b
and neurotransmitters, or by growth factor with-
drawal. Inhibitors of apoptosis include the CD40
w xligand, estrogens, and several viral genes 13 . The
mechanism by which these agents affect programmed
cell death has been the subject of increasing studies.
Certain oncogenes, myc, rel, or E1A, and the tumor
suppressor gene p53 have been linked to induction of
apoptosis by these agents, depending on the cell type
w x w xtested 14–16 . The gene Bcl-2 17,18 , however, has
been linked to inhibition of apoptosis. Overexpres-
sion of Bcl-2 specifically prevents cells from initiat-
ing apoptosis in response to a number of stimuli
w x15,8,19 .
NO has been linked to the induction of apoptosis
w xin some cell types 13 and NO production is inti-
mately linked to cellular glutathione content and re-
w xdox state 7–9 . In the current study we demonstrate
that NO induces p53 and activates programmed cell
death in VSM cells and that these effects depend on
an NO-induced decrease of intracellular reduced glu-
tathione. NO-induced apoptosis may be important for
arterial remodeling following vascular injury or in
other pathologic states in which vascular smooth
muscle cell proliferation is altered.
2. Materials and methods
2.1. Cell culture
Smooth muscle cells were isolated from the thor-
atic aorta of Sprague–Dawley rats Charle River
.Breeding Laboratories . Isolation procedures, using
enzymatic disaggregation of tissue, and culturing
w xconditions were described previously 20,21 . Cells
were used for experiments between passage numbers
3–6. Cell number and viability were determined with
a hemocytometer and staining with trypan blue, re-
spectively.
2.2. Determination of DNA synthesis and cell number
Vascular smooth muscle cells were seeded in 25
cm2 flasks at concentrations of 0.5=106 cellsr5 ml
medium. Duplicate flasks were either subjected to
cell counting or to pulse labeling for determination of
DNA synthesis. In order to determine cell number the
cells were scraped off the plate in the presence of
 . phosphate buffered saline PBS 10 mM sodium
.phosphate; 150 mM NaCl, pH 7.4 , stained with
trypan blue, to exclude non-viable cells, and counted
with a hemocytometer. Cells in duplicate flasks were
w3 x subjected to pulse labeling with H thymidine 15
.  .mCir5 ml DuPont NEN, Boston, MA for 1 h. At
the end of the pulse labeling the medium was dis-
carded and the cells were washed with PBS. Cells
were extracted with 1.5 ml of 5% trichloroacetic acid
 .TCA for 30 min at room temperature. TCA was
discarded and the cell precipitate was washed with an
additional 2 ml TCA. Precipitates were dissolved in
0.5 ml of 1 N NaOH which was then added to a
scintillation vial containing 5 ml scintillation cocktail
 .Fisher Scientific, Springfield, NJ and counted in a
scintillation counter.
2.3. Determination of nitrite le˝els in medium
Nitrite concentrations were determined using the
Griess reagent, essentially as described previously
w x  .22 . Aliquots of media 400 ml were mixed with
equal volumes of the Griess reagent a solution con-
 .taining 1% sulfanilamide and 0.1% N- 1-naphthyl
.ethylenediamine in 2% phosphoric acid and the opti-
cal density was determined at 540 nm. A standard
w xcurve was generated using sodium nitrite 22 .
2.4. Determination of apoptosis
Apoptosis was detected by analyzing the presence
w xof DNA ‘laddering’ on 1% agarose gels 23 , as well
as by flow cytometric determination of DNA content
w xby staining with propidium iodide 24 , and staining
by propidium iodide of nuclei of unpermebialized
cells. Apoptosis was also determined in situ by An-
nexin V staining of the plasma membrane. To this
end, rat vascular smooth muscle cells were seeded at
1=104 to 2=104 cells welly1 in Nunc 16-well
tissue culture slides Nalge Nunc International,
.Naperville, IL in 200 ml of DMEMr10% FBS
supplemented with 1% penicillin–streptomycin 5000
.Urmlr5000 mgrml , 1% MEM non-essential amino
 . acids 10 mM and 1% MEM sodium pyruvate 100
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. w xmM , and cultured as described elsewhere 16,17 .
After 18 h of incubation, the cells were stimulated
with various nitric oxide donors: sodium nitroprus-
 .  .side SNP Sigma, St. Louis, MO , and NOC-18,
 . w  . DETArNO, Z -1- 2- 2-aminoethyl -N- 2-am-
. x x monioethyl amino diazen-1-lum-1,2-diolate DETA
.  .NONOate Alexis Corporation, San Diego, CA .
Cells were incubated in the presence of these donors
at 378C for the time indicated. Cells undergoing
apoptosis were characterized by immunofluorescence
staining with FITC-labeled Annexin V, as described
in the Annexin apoptosis detection kit R&D Sys-
.tems, Minneapolis, MN . Following the incubation,
fluorescent-labelled cells were examined using an
inverted fluoroscope.
2.5. Northern blot analysis
RNA isolation and Northern blot analyses were
w xperformed as described previously 24 . The blots
were probed with cDNA encoding either mouse p53
 . generous gift of Dr. T. Jacks or c-myc generous
.gift of Dr. G. Sonenshein or with actin cDNA as a
control.
2.6. Determination of intracellular reduced glu-
tathione concentration
VSM cells were treated for 24 h with either 1 mM
 . y1sodium nitroprusside SNP or 10 mg ml lipopoly-
 .saccharide LPS , with or without 0.5 mM glu-
 .tathione monoethyl-ester Sigma,, St. Louis, MO . At
the end of the incubation, the cells were washed
twice with an excess of PBS and precipitated with
80% perchloric acid. Samples were centrifuged for 10
min at 1000=g and supernatant collected. Super-
 .natants were analyzed for reduced glutathione GSH
using high performance chromatography with an
w xelectrochemical detector as described previously 25 .
3. Results
3.1. Effect of an NO donor on DNA synthesis and
apoptosis in ˝ascular smooth muscle cells
We studied the effect of NO on DNA synthesis
and cell growth in cultures of rat VSM cells. NO
Table 1
Nitric oxide inhibits DNA synthesis and cell growth in vascular
smooth muscle cells
3 . w xAddition Nitrite mM H Thymidine Cell number
6 .incorporation =10
3 .dpm=10
None ND 6.8"1.9 3.7"0.6
SNP 19.7"2.0 2.7"0.6 1.4"0.2
VSM cells were cultured in the absence or presence of the NO
donor SNP at a concentration of 1 mM for 20 h, after which the
medium and cells were collected for different analyses as de-
scribed under Section 2. The results represent averages of three
experiments with an indicated standard deviation. ND, not de-
tectable.
 .generated by sodium nitroprusside SNP caused a
 .significant inhibition of DNA synthesis Table 1 .
Proliferation of cell populations depends both on
completion of full mitotic cell cycles and on rates of
cell death. Fragmentation of genomic DNA has been
well established as a clear criterion for programmed
w xcell death 23 . As shown in Fig. 1, NO generated by
SNP or by an NO-releasing compound which does
not release cyanide, DETA NONOate, induced apop-
tosis in VSM cells, as indicated by DNA fragmenta-
tion. Well characterized responses to NO, such as
inhibition of DNA synthesis and relaxation of smooth
Fig. 1. Nitric oxide, but not cGMP, induces apoptosis in vascular
smooth muscle cells. VSM cells were cultured for 24 h in the
 .  .absence lane1 or presence of 0.2 mM 8-bromo-cGMP lane 2 ,
 .or in the presence of 1 mM SNP lanes 3 , or in the presence of
 .0.5 mM DETA NONOate lane 4 . DNA prepared from cells was
 .fractionated on 1% agarose gel 10 mgrlane . A 1 kb DNA
 .ladder GIBCO–BRL, Gaithersburg, MD was used as a marker
 .M .
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w xmuscle, are cGMP-mediated 5,26 . The cGMP ana-
log, 8-bromo-cGMP, did not mimic the effect of NO
 .on apoptosis in VSM cells Fig. 1 . We used two
additional criteria for monitoring apoptosis: one in-
volves flow cytometry analysis of the fraction of
DNA stained by propidium iodide and which does
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Fig. 3. In situ analysis of apoptosis in VSM cells treated with NO donors. VSM cells were incubated in the presence of 0.5 mM DETA
 .  .NONOate A,B or in the absence of an NO-donor C,D for 24 h, after which they were stained with FITC-labeled Annexin V. Cells
 .  .were viewed under phase A,C or fluorescent B,D microscope. Magnification =250. Results are representative of three experiments.
The arrows point to some of the cells undergoing apoptosis. Similar results to the one shown in panel D were obtained when cells were
 .incubated with SNP not shown . Other details are under Section 2.
not correspond to diploid or higher ploidy sets of
chromosomes; and the second is based on the ability
of apoptotic cells to bind Annexin V due to changes
w xin the cell membrane structure 27 . As shown in Fig.
2, flow cytometry analysis indicated that the fraction
of cells undergoing apoptosis increased in proportion
to the concentration of nitrite produced by SNP. In
 .accordance, a similar fraction about 15–30% of the
 .cells treated with DETA NONOate Fig. 3 or SNP
 .not shown displayed a clear binding to Annexin V
as revealed by in situ staining, while control cells did
not display a significant binding.
3.2. Effect of lipopolysaccharides on apoptosis in
˝ascular smooth muscle cells
The production of NO from the guanidino nitrogen
atom of L-arginine is mediated by the action of a
w xgroup of enzymes known as NO synthases 5 . In
endothelial cells, an isozyme is expressed constitu-
 .Fig. 2. A Flow cytometric analysis of VSM cells treated with SNP. Cells were incubated with different concentrations of SNP for 24 h,
w x  .collected and stained with propidium iodide and subjected to flow cytometry analysis 24,50 . The area indicated as M2 is of 2N diploid
and 4N cells, while the area indicated as M1 represents the fragmented DNA in apoptotic cells. At a concentration of 1 mM SNP, the
 .calculated area of M1 was arbitrarily defined as 100% which represented approximately 25% of the cells in culture . In comparison to
 .this latter M1, the area of M1 in cells treated with 0.5 mM SNP was 55%. B Nitrite produced by VSM cells treated with different
concentrations of SNP. Nitrite was not detectable in control cells by the method of detection employed. Results are averages"SD of
three determinations in each bar.
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Fig. 4. Effect of lipopolysacharides on apoptosis. VSM cells were
 . incubated in the absence lane 1 , or presence of LPS 10 mg
y1.  .  .ml lane 2 , or LPS plus 5 mM L-NMA lane 3 , or LPS and
 .500 mM GSH monoethylester lane 4 , or 1 mM SNP and 500
 .mM GSH monoethylester lane 5 for 24 h. DNA prepared from
 .cells was fractionated 10 mgrlane on 1% agarose gel. A 1 kb
 .  .DNA ladder GIBCO-BRL was used as a marker M . In
LPS-treated cells, the average level of nitrite determined in the
 .medium see Section 2 was 1 mM, while the level in non-treated
cells was not detectable. The results are representative of three
experiments.
tively and is described as a calmodulin-dependent
w xenzyme 5 . Inducible forms of NO synthase, which
 .are activated by interleukin-1b IL-1b or by lipo-
 .polysaccharide LPS , have been identified in various
cell types, including vascular smooth muscle cells
w x20 . We found that LPS-induced NO production led
to apoptosis in VSM cells. LPS-induced programmed
cell death was abolished by an NO synthase inhibitor,
G w x  .  .N -monomethyl-L-arginine 28 L-NMA Fig. 4 .
This suggested that increased activity of NO synthase
was fundamental for induction of apoptosis.
3.3. Effect of sodium nitroprusside and lipopolysac-
charides on the le˝el of reduced glutathione in ˝ascu-
lar smooth muscle cells
Since NO-induced apoptosis is cGMP indepen-
dent, we tested the possibility that the effect of NO,
produced by either SNP or LPS, was dependent on its
 .effects on the levels of reduced glutathione GSH .
We focused on GSH since NO reacts with a variety
of thiol groups, either on proteins or in the form of
w xglutathione, to exert various biologic effects 29 . The
level of NO available to react with thiol groups on
proteins would be affected by GSH availability in the
cells. As may be expected, LPS or SNP significantly
 .decreased the level of GSH in VSM cells Table 2 .
Addition of reduced glutathione glutathione mo-
w xnoethylester, which enters cells freely 30 prevented
this NO-induced reduction in intracellular GSH Ta-
.ble 2 . More interestingly, raising the concentration
of reduced glutathione in the cells also prevented
NO-induced apoptosis, as indicated by a complete
 .lack of laddering of genomic DNA Fig. 4 .
3.4. The le˝els of p53 and c-myc in VSM cells
exposed to high le˝els of NO
Induction of apoptosis in some cell types has been
linked to high expression of the oncogene myc and in
other lineages to the tumor suppressor gene p53
w x14–16,31 . In VSM, c-myc is elevated in response to
mitogens while it is down regulated in response to
w xfactors that induce growth arrest 32,33,26 . We,
therefore, tested whether NO-induced apoptosis in
VSM cells is associated with alterations in the levels
of c-myc andror p53 mRNAs. As shown in Fig. 4,
within 8 h of treatment with LPS there was a signifi-
cant increase in the level of p53 mRNA and a
Table 2
Effect of NO on the intracellular level of GSH
 .Addition GSH mmolrg protein
 .None 9.69"3.64 11
 .LPS 5.82"1.89 10
 .SNP 5.91"1.19 10
 .GSHe 19.67"4.96 6
 .LPSqGSHe 8.97"1.53 3
 .SNPqGSHe 9.19"1.70 3
VSM cells were cultured in the absence or presence of the NO
donor SNP at a concentration of 1 mM or with LPS 10 mg
y1.ml for 24 h, in the absence or presence of 500 mM GSH
 .monoethyl-ester GSHe . Intracellular GSH was determined as
described under Section 2. The results represent the average"
standard deviation for the number of experiments indicated in
parentheses. The statistical significance between the treatment
groups was determined with Students-test. When comparing the
values in control and SNP-treated or control and LPS-treated
 .cells, the differences were statistically significant P -0.001 .
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Fig. 5. Lipopolysaccharide increases the level of p53 mRNA in
 .VSM cells. VSM cells were incubated in the absence lanes 1,2
 y1.  .  .or presence of LPS 10 mg ml lanes 3,4 for 8 h lanes 1,3
 .or 24 h lanes 2,4 . Northern blot analyses were performed on
RNA isolated from cells incubated under the different conditions
indicated. Blots, loaded with 10 mg RNA in each lane, were
probed with either cDNA encoding mouse p53 or c-myc or with
actin cDNA to confirm equal loading.
decrease in the level of myc mRNA. The alterations
in the levels of these specific mRNAs were not
transient, as concluded from analyzing cells cultured
 .for longer incubation times Fig. 4 . It is of interest to
note that a recent study has shown that apoptosis
occurs in restenotic and atherosclerotic lesions of the
blood vessel in association with detectable levels of
w xp53 34 . Increased concentrations of reduced glu-
tathione in the cells also prevented the NO-induced
 .increase in p53 Fig. 5 . It should be pointed out that
the available antibodies to human p53 recognize
mouse protein but not the rat p53, thus preventing us
Fig. 6. GSH monoethyl-ester abolishes NO-induced increase in
 .p53. VSM cells were incubated in the absence lane 1 or
 y1.  .presence of LPS 10 mg ml lane 2 , or LPS plus 500 mM
 .GSH monoethylester lanes 3 for 24 h. Northern blot analyses
were performed on RNA isolated from cells. Blots, loaded with
10 mg RNA in each lane, were probed with cDNA encoding
 .mouse p53 or with actin cDNA to confirm equal loading . GSH
monoethylester added alone did not affect the baseline level
 .  .non-treated cells of p53 data not shown .
from following the level of p53 protein in our experi-
ments. It is, however, reasonable to assume that
conditions which result in equal levels of p53 mRNA
untreated cells and cells treated simultaneously with
.NO and GSHe should lead to comparable levels of
p53 protein. Since the level of p53 mRNA was
increased in cells treated with NO but restored to
control levels in the presence of GSH, and since GSH
also inhibited NO-induced apoptosis, it is conceivable
that the effect of NO on apoptosis is related to
 .upregulation of p53 Fig. 6 .
4. Discussion
Inducible forms of NO synthase can be activated
 .  .by interleukin IL -1b or lipopolysaccharide LPS in
w xnumerous tissues 27,5 . IL-1b or LPS-induced pro-
duction of NO leads to elevation of intracellular
w xcGMP 3,35 , resulting in inhibition of cell prolifera-
w xtion 35 . In the current study, we have sought to
determine whether the effect of nitric oxide on cell
growth in VSM involves induction of programmed
cell death. We found that NO generated by SNP or
synthesized in VSM induced DNA fragmentation
typical for apoptosis. It is of particular interest to note
that in B lymphocytes NO inhibits apoptosis, also
w xdetermined by DNA fragmentation 36 , indicating
that the nature of the effect of NO depends on
lineage-specific signaling. In agreement with our re-
w xsults, Geng and colleagues 37 reported recently that
IL-1b induces human VSM cells to produce nitrite
and to undergo apoptosis, as indicated by DNA frag-
mentation. Our study, however, has been extended to
explore the potential mechanisms by which NO in-
duces programmed cell death.
Regulation of apoptosis has been extensively stud-
ied in the past few years. Apoptosis is inhibited in a
variety of cell types by physiologic effectors, such as
CD40 ligand, and by several viral genes. Inducers of
apoptosis include members of the TNF family, TGF-
b, growth factor withdrawal, and inducers of DNA
w xdamage 13 . In order to explore the mechanism by
which apoptosis is initiated, the levels of different
oncogenes and tumor suppressor genes were deter-
mined in cells treated with the above agents. Tumors
that are deficient in p53 have enhanced resistance to
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DNA damage and a delayed programmed cell death
w xresponse 15 . Elevated c-myc expression in CHO
cells or in fibroblasts with a block to cell prolifera-
w xtion induces apoptosis 31,38 . c-myc, however, also
plays a central role in the proliferation of many cell
types, including VSM cells. c-myc is induced in
VSM cells exposed to mitogens or after balloon
catheter arterial injury, and remains elevated through
w xout the cell cycle 39 . In accordance with this latter
study, incubation of VSM cells with a cGMP analog
results in downregulation of c-myc leading to arrest
w xin cell growth 26 . These studies have led to the
hypothesis that c-myc presents a ‘two signal’ model
in which it can provide a signal leading to apoptosis
or a signal leading to proliferation, depending on the
cell type and cell cycle conditions. In the present
study, we found that NO-induced apoptosis in VSM
cells was accompanied by a decrease in the level of
c-myc and a significant elevation of p53 mRNA.
Some responses to NO, such as inhibition of DNA
synthesis, relaxation of VSM cells or inhibition of
w xplatelet aggregation, are cGMP-mediated 40 . Our
study indicated that a cGMP analog did not mimic
the effect of NO on apoptosis in VSM cells. NO
effects that are independent of cGMP could be in-
duced via reaction with thiol groups, as well as with
oxygen, superoxide, or transition metals, yielding
products that support additional nitrosative reactions,
w xparticularly S-nitrosothiol formation 5,29 . In the
current study, we found that NO-induced apoptosis in
VSM cells was associated with a significant decrease
 .in the level of reduced glutathione GSH in the cells.
Moreover, increasing levels of reduced glutathione in
cells cultured with GSH monoethylester, prevented
the NO-induced increase in p53 and protected against
NO-induced apoptosis. These findings are consistent
with several other reports on other systems. Petit and
w xcolleagues 41 have recently shown that glutathione
protects against the antiproliferative effects of nitric
oxide, but did not examine if some of the effect
reflects an influence on the apoptotic process. Slater
w xand colleagues 42 have demonstrated that thymo-
cyte apoptosis is associated with a 40% decrease in
intracellular GSH levels. In additions, it has been
demonstrated that augmentation of cellular GSH with
N-acetylcysteine attenuates apoptosis in U937 cells
w x w x43 . Furthermore, Kane and colleagues 44 have
recently shown that expression of the proto-oncogene
Bcl-2, a known inhibitor of apoptosis, is associated
with an increase in intracellular GSH.
Our studies implicate GSH as having an essential
role in protecting VSM cells from apoptosis. Our
findings also demonstrate that high levels of GSH in
the VSM cells prevent NO-induced increases in p53,
a known stimulator of apoptosis. It is possible that
GSH at high levels competes with other proteins for
NO and, thus, reduces NO-induced modification of
thiol groups on proteins, the later being potentially
important for inducing apoptosis. For example, it has
been shown that NO decreases the number of thiol
groups in G proteins, resulting in direct nuclear
translocation and activation of the transcription factor
w xNF-kB 45 . Since NF-kB stimulates the production
w xof p53 46 , it is conceivable that NO-induced upreg-
ulation of p53 is mediated via activation of NF-kB.
The suggestion that NO induces apoptosis in VSM
cells via p53 would be consistent with studies in
other cell types in which apoptosis was attributed to
w xinduction of p53 13,15 . Alternatively, since NO also
alters the level of GSH in VSM cells, it is possible
that GSH per se, by an as yet unidentified mecha-
nism, prevents apoptosis, as suggested by Cossarizza
w xand colleagues 47 . Our data, however, do not ex-
clude the possibility that NO-mediated changes in the
intracellular redox state are effecting the expression
of other potential regulators of apoptosis in vascular
w xsmooth muscle, such as Fas protein 48 . Regardless
of the nature of the end target of NO signaling e.g.,
.p53 orrand Fas , the effect on apoptosis seems to be
mediated by changes in GSSGrGSH, as access of
GSH prevents NO-induced programmed cell death.
The functional significance of apoptosis in VSM
cells is probably critical in determining arterial struc-
ture, and remodelling in response to injury. Although
luminal smooth muscle cells divide at high rate fol-
lowing arterial trauma, intimal thickening ultimately
w xceases 10 . These studies imply that cell death pre-
vents complete occlusion of the artery. Our results
provide a mechanism by which NO, either originating
from endothel cells or produced in VSM cells them-
selves, could influence cell growth in the vasculature.
w xWe propose that availability of IL-1b in lesions 49 ,
and thus increased levels of NO, should initiate a
cGMP-dependent inhibition of DNA synthesis as well
as a cGMP-independent activation of apoptosis, which
can be prevented by increasing intracellular GSH.
( )Z. Zhao et al.rBiochimica et Biophysica Acta 1359 1997 143–152 151
Acknowledgements
We thank Judith Ann Foster and Celeste Rich for
generous gift of freshly isolated rat smooth muscle
cells; Taylor Jacks and Gail Sonenshein for providing
us the mouse p53 and c-myc cDNAs, respectively;
and Ying Zhang for the flow cytometry analysis. KR
is an Established Investigator with the American
Heart Association. This work was supported in part
by NIH grants HL48743, HL53919, HL55993, and a
Merit Review Award from the US Veteran Adminis-
tration.
References
w x1 S.M. Schwartz, R.L. Heimark, M.W. Majesky, Develop-
mental mechanisms underlying pathology of arteries, Phys-
 .iol. Rev. 70 1990 1177–1209.
w x2 F.W. Keeley, D. Johnson, The effect of developing hyper-
tension on the synthesis and accumulation of elastin in the
 .aorta of the rat, J. Biochem. Cell. Biol. 64 1986 38–43.
w x3 U.C. Garg, A. Hassid, Nitric oxide-generating vasodilators
and 8-bromo-cyclic GMP inhibit mitogenesis and prolifera-
tion of cultured rat vascular smooth muscle cells, J. Clin.
 .Invest. 83 1989 1774–1777.
w x4 B. Jonzon, J. Nilsson, B.B. Fredholm, Adenosine receptor
mediated changes in cyclic AMP production and DNA
synthesis in cultured arterial smooth muscle cells, J. Cell.
 .Physiol. 124 1985 451–456.
w x5 C.F. Nathan, Q.W. Xie, Nitric oxide synthases: roles, tolls,
 .and controls, Cell 78 1994 915–918.
w x6 P.C. Kuo, K.Y. Abe, Nitric oxide-associated regulation of
hepatocyte glutathione synthesis is a guanylyl cyclase-inde-
 .pendent event, Surgery 120 1996 309–314.
w x7 H. Hofmann, H.H. Schmidt, Thiol dependence of nitric
 .oxide synthase, Biochemistry 34 1995 13443–13452.
w x8 D.L. Duval, D.J. Sieg, R.E. Billings, Regulation of hepatic
nitric oxide synthase by reactive oxygen intermediates and
 .glutathione, Arch. Biochem. Biophys. 316 1995 699–702.
w x9 D. Ghigo, P. Alessio, A. Foco, F. Bussolino, C. Costam-
agna, R. Heller, G. Garbarino, G.P. Pescarmona, A. Bosia,
nitric oxide synthesis is impaired in glutathione-depleted
human umbilical vein endothelial cells, Am. J. Physiol. 265
 .1993 C728–C732.
w x10 A. Cho, D.W. Courtman, B.L. Langille, Apoptosis in arter-
 .ies of the neonatal lamb, Circ. Res. 76 1995 168–175.
w x11 M.C. Raff, Social control on cell survival and cell death,
 .Nature 356 1992 397–400.
w x12 M.D. Jacobson, J.F. Burne, M.C. Raff, Programmed cell
death and Bcl-2 protection in absence of a nucleus, EMBO
 .J. 13 1994 1899–1910.
w x13 C.B. Thompson, Apoptosis in the pathogenesis and treat-
 .ment of disease, Science 267 1995 1456–1462.
w x14 S.W. Lowe, E.M. Schmitt, S.W. Smith, B.A. Osborn, T.
Jacks, p53 is required for radiation-induced apoptosis in
 .mouse thymocytes, Nature 362 1993 847–849.
w x15 S.W. Lowe et al., p53 states and the efficacy of cancer
 .therapy in vivo, Science 266 1994 807–811.
w x16 C. Caelles, A. Heimberg, M. Karin, p53-dependent apopto-
sis in the absence of transcriptional activation of p53-target
 .gene, Nature 370 1994 220–223.
w x17 Y. Tsujimoto, J. Gorha, J. Cossman, E. Jaffe, C.M. Corce,
 .The t 14;18 chromosome translocations involved in B-cell
neoplasms result from mistakes in VDJ joining, Science 229
 .1985 1390–1393.
w x18 D.M. Hockenbery, G. Nunez, C. Milliman, R.D. Schreiber,
S.J. Korsmeyer, Bcl-2 is an inner mitochondrial membrane
protein that blocks programmed cell death, Nature 348
 .1990 334–337.
w x19 D.L. Vaux, S. Cory, J.M. Adams, Bcl-2 gene promotes
haemopoietic cells survival and cooperates with c-myc to
 .immortalize pre-B cells, Nature 335 1988 440–442.
w x20 T. Scott-Burden, V.B. Schini, E. Elizondo, D.C. Junquero,
P.M. Vanhoutte, Platelet-derived growth factor suppresses
and fibroblast growth factor enhances cytokine-induced pro-
duction of nitric oxide by cultured smooth muscle cells:
 .Effect on cell proliferation, Circ. Res. 71 1992 1088–1100.
w x21 B.L. Wolfe, C.B. Rich, H.D. Goud, A.J. Terpstra, M. Bashir,
J. Rosenbloom, G.E. Sonenshein, J.A. Foster, Insulin-like
growth factor-I regulates transcription of the elastin gene, J.
 .Biol. Chem. 268 1993 12418–12426.
w x22 L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S.
Wishnok, S.R. Tannenbaum, Analysis of nitrate, nitrite and
w15 x  .N nitrate in biological fluids, Anal. Biochem. 126 1982
131–138.
w x23 C.A. Smith, G.T. Williams, R. Kingston, E.J. Jenkinson,
J.J.T. Owen, Antibodies to CD3rT-cell receptor complex
induce death by apoptosis in immature T cells in thymic
 .cultures, Nature 337 1989 181–184.
w x24 K. Ravid, Y.C. Li, H.B. Rayburn, R.D. Rosenberg, Targeted
expression of a conditioned oncogene in hematopoietic cells
 .of transgenic mice, J. Cell Biol. 123 1993 1545–1553.
w x25 L. Allison, R. Shoup, Dual electrode liquid chromatography
 .for thiols and disulfides, Anal. Biochem. 55 1983 8–12.
w x26 M.R. Bennett, G.I. Evan, A.C. Newby, Deregulated expres-
sion of the c-myc oncogene abolishes inhibition of prolifera-
tion of rat vascular smooth muscle cells by serum reduction,
interferon-g, heparin, and cyclic nucleotide analogues and
 .induces apoptosis, Circ. Res. 74 1994 525–536.
w x27 G. Koopman, C.P. Reutelingsperger, G.A. Kuijten, R.M.
Keehnen, S.T. Pals, M.H. van Oers, Annexin V for flow
cytometric detection of phosphatidylserine expression on B
 .cells undergoing apoptosis, Blood 84 1994 1415–1420.
w x28 J.S. Stamler, D.J. Singel, J. Loscalzo, Biochemistry of nitric
 .oxide and its redox-activated forms, Science 258 1992
1898–1902.
w x29 J.S. Stamler, Redox signaling: nitrosylation and related tar-
 .get interactions of nitric oxide, Cell 78 1994 931–936.
w x30 G.N. Welch, J. Upchurch, J. Loscalzo, Stimulation of nitric
( )Z. Zhao et al.rBiochimica et Biophysica Acta 1359 1997 143–152152
oxide production by endothelial cells detoxifies
 .  .homocyst e ine, J. Blood 86 1995 378A.
w x31 R.P. Bissonnette, F. Echeverri, A. Mahboubi, D.R. Green,
Apoptotic cell death induced by c-myc is inhibited by bcl-2,
 .Nature 359 1992 552–554.
w x32 M. Dean, R.A. Levine, W. Ran, M.S. Kindy, G.E. Sonen-
shein, J. Campisi, Regulation of c-myc transcription and
mRNA abundance by serum growth factors and cell contact,
 .J. Biol. Chem. 261 1986 9161–9166.
w x33 E.R. Edelman, M. Simons, M.G. Sirois, R.D. Rosenberg,
 .c-myc in vasculoproliferative disease, Circ. Res. 76 1995
176–182.
w x34 J.M. Isner, M. Kearney, Bortman, S., and Passeri, Apoptosis
 .in human atherosclerosis and restenosis, J. Circ. 91 1995
2703–2711.
w x35 T. Nakaki, S. Yamamoto, M. Nakayama, R. Kato, in: M.
 .Fujiwara, S. Narmiya, S. Miwa Eds. , Biosignaling in
Cardiac and Vascular Systems, Pergamon Press, Oxford,
1989, pp. 66–69.
w x36 J.B. Mannick, K. Asano, K. Izumi, E. Kieff, S. Stamler,
Nitric oxide produced by human B lymphocytes inhibits
 .apoptosis and Epstein-Barr virus reactivation, Cell 79 1994
1137–1146.
w x37 Y.J. Geng, Q. Wu, M. Muszynski, K. Hansson, P. Libby,
Apoptosis of vascular smooth muscle cells induced by in
vitro stimulation with interferon-g, tumor necrosis factor-a ,
and interleukin-1b, Arterioscler. Thromb. Vasc. Biol. 16
 .1996 19–27.
w x38 G.I. Evan, A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H.
Land, M. Brooks, C.M. Waters, L.Z. Penn, D.C. Hancock,
Induction of apoptosis in fibroblasts by c-myc protein, Cell
 .69 1992 119–128.
w x39 J.M. Miano, R.R. Tota, N. Vlasic, K.Y. Danishefsky, M.B.
Stemerman, Early proto-oncogene expression in rat aortic
smooth muscle cells following endothelial removal, Am. J.
 .Pathol. 137 1990 761–765.
w x40 S. Moncada, R.M. Palmer, E.A. Higgd, Nitric oxide: physi-
ology, pathology and pharmacology, Pharmacol. Rev. 43
 .1991 109–142.
w x41 J.F. Petit, M. Nicaise, M. Lepoivre, A. Guissani, G. Lemaire,
Protection by glutathione against the antiproliferative effects
of nitric oxide. Dependence on kinetics of NO release,
 .Biochem. Pharm. 52 1996 205–212.
w x42 A.F.G. Slater, S.I. Nobel, E. Maellaro, J. Bustamante, M.
Kimland, S. Orrenius, Nitrone spin trap and nitroxide an-
tioxidant inhibit a common pathway of thymocyte apoptosis,
 .Biochem. J. 306 1995 771–778.
w x43 A. Cossarizza, C. Franchesi, D. Monti, Protective effect of
N-acetylcysteine in tumor necrosis factor-alpha-induced
apoptosis in U937 cells: the role of mitochondria, Exp. Cell
 .Res. 220 1995 232–240.
w x44 D.J. Kane, T.A. Sarafian, R. Anto, Bcl-2 inhibition of neural
death: decreased generation of reactive oxygen species,
 .Science 262 1993 1274–1277.
w x45 H.M. Lander, P. Sehajpal, D.M. Levine, A.J. Novogrodsky,
Activation of human peripheral blood mononuclear cells by
 .nitric oxide-generating compounds, J. Immunol. 150 1993
1509–1516.
w x46 H. Wu, G. Lozano, NF-kB activation of p53: A potential
mechanism for suppressing cell growth in response to stress,
 .J. Biol. Chem. 269 1994 20067–20074.
w x47 A. Cossarizza, C. Franchesi, D. Monti et al., Protective
effect of N-acetylcystein in tumor necrosis factor-alpha-in-
duced apoptosis in U937 cells: the role of mitochondria,
 .Exp. Cell Res. 220 1995 232–240.
w x48 K. Fukuo, S. Hata, T. Suhara, T. Nakahashi, Y. Shinto, Y.
Tsujimoto, S. Morimoto, T. Ogihara, Nitric oxide induces
upregulation of Fas and apoptosis in vascular smooth mus-
 .cle, Hypertension 27 1996 823–826.
w x49 N. Haeffner-Cavaillon, N. Roussellier, O. Ponzio, P. Car-
reno, M. Laude, A. Carpentier, M.D. Kazatchkine, Induction
of interleukin-1 production in patients undergoing cardiopul-
 .monary bypass, J. Thorac. Cardiovasc. Surg. 98 1989
1100–1106.
w x50 Y. Zhang, Z. Wang, K. Ravid, The cell cycle in polyploid
megakaryocytes is associated with reduced activity of cyclin
 .B1-dependent CDC2 kinase, J. Biol. Chem. 271 1996
4266–4272.
